Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
4.100
-0.010 (-0.25%)
Apr 16, 2026, 12:35 PM EDT - Market open
Purple Biotech Employees
Purple Biotech had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$2,638,600
Market Cap
6.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 1 | 11.11% | 10 | 0 |
| Dec 31, 2024 | 9 | -11 | -55.00% | 9 | 0 |
| Dec 31, 2023 | 20 | 0 | - | 20 | 0 |
| Dec 31, 2022 | 20 | 1 | 5.26% | 20 | 0 |
| Dec 31, 2021 | 19 | 6 | 46.15% | 19 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| KALA BIO | 38 |
| Aptevo Therapeutics | 33 |
| FibroBiologics | 15 |
| BioRestorative Therapies | 14 |
| XTL Biopharmaceuticals | 10 |
| Immuron | 7 |
| Ernexa Therapeutics | 7 |
| Can-Fite BioPharma | 5 |
PPBT News
- 4 weeks ago - Purple Biotech Announces CEO Transition - GlobeNewsWire
- 7 weeks ago - Purple Biotech Announces Plan to Implement ADS Ratio Change - GlobeNewsWire
- 4 months ago - Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress - GlobeNewsWire
- 5 months ago - Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform - GlobeNewsWire
- 6 months ago - Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 7 months ago - Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants - GlobeNewsWire
- 8 months ago - Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire